MyFinsight
Home
Blog
About
Contact
Download
Download image
Maturities of marketable
securities
$81,711K
Trade accounts
receivable
-$16,431K
Proceeds from sale of
fixed assets
$8K
Equity-based compensation
$9,890K
Depreciation and
amortization
$6,000K
Other current and
long-term assets
-$2,791K
Customer deposits
$2,470K
Adjustment for credit
losses
$1,189K
Noncash lease expense
$352K
Unrecognized tax benefits
-$199K
Other
-$1K
Net cash provided by
(used in) investing...
$10,939K
Net cash (used in)
provided by operating...
$7,097K
Effect of exchange rate
changes on cash and cash...
$3K
Canceled cashflow
$70,780K
Canceled cashflow
$32,226K
Net (decrease)
increase in cash, cash...
-$26,794K
Canceled cashflow
$18,039K
Proceeds from exercise of
stock options
$9K
Acquisition of businesses,
net of cash
$55,567K
Purchase of marketable
securities
$10,011K
Purchases of fixed assets
$5,202K
Net loss from
consolidated operations
-$25,274K
Accrued liabilities and
other liabilities
-$2,123K
Income tax
-$1,394K
Deferred taxes
-$1,120K
Amortization of discount of
marketable securities
$890K
Contract liabilities
-$627K
Accounts payable
-$408K
Operating lease
liabilities
-$381K
(gain) loss on disposal
of fixed asset
$9K
Net cash used in
financing activities
-$44,833K
Canceled cashflow
$9K
Repurchase of common stock
$40,078K
Common stock
withholding for employee tax...
$4,200K
Repayment of notes payable
$476K
Principal paid for finance
lease
$88K
Back
Back
Cash Flow
source: myfinsight.com
Fulgent Genetics, Inc. (FLGT)
Fulgent Genetics, Inc. (FLGT)